Comparison of volume output from two different continuous nebulizer systems

Annals of Allergy, Asthma and Immunology

Volumn 76, Issue 2, 1996, Pages 209-213

  Reisner, Colin ^a,b   Lee, Joseph ^a   Kotch, Arthur ^a   Dworkin, Gregory ^a  

^a DANBURY HOSPITAL   (United States)

^b BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;

ARTICLE; ASTHMA; DEVICE; DOSE RESPONSE; DRUG DELIVERY SYSTEM; HUMAN; NEBULIZATION; NEBULIZER; PHARMACEUTICS; PRACTICE GUIDELINE; PRIORITY JOURNAL;

EID: 0030047681     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)63424-2     Document Type: Article

References (16)

1. National Asthma Education Program Expert Panel Report. J Allergy Clin Immunol 1991;88:425-534.
2. 2 in children with severe asthma treated with continuously nebulized terbutaline. J Allergy Clin Immunology 1988;81:1101-9.
3. Willsie-Ediger SK, Salzman G, Oki J, et al. Continuous versus intermittent nebulization of albuterol in status asthmaticus - a prospective study [Abstract]. Chest 1992;102:91S.
4. Willsie-Ediger SK, Salzman G, Seta T, et al. Continuously nebulized albuterol in acute bronchospasm - is it xafe [Abstract]. Chest 1992;102:91S.
5. Portnoy J, Nadel G, Amadd M, Willsie-Ediger SK. Continuous nebulization for status asthmaticus. Ann Allergy 1992;69:71-9.
6. Colacone A, Wolkove N, Stern E, et al. Continuous nebulization of albuterol (salbutamol) in acute asthma. Chest 1990;97:693-7.
7. Reisner C, Kotch A, Dworkin G. Continuous versus frequent intermittent nebulization of albuterol in acute asthma-a randomized prospective study. Ann Allergy, Asthma, & Immunol 1995;75:41-7.
8. Reisner C, Kotch A, Dworkin G. Continuous nebulization in asthma: Description of a simple technique. Am J Asthma Allergy Pediatr 1993;6:181-2.
9. Cohn JR, Caliguiri LA, Gallagher PE, Schenkel EJ. Commentary: prevention and cost of asthma - a model for cost effective health care. Allergy Proc 1994;15:39-41.
10. Spitzer WO, Suissa S, Ernst P, et al. The use of beta-agonists and the risk of death and near death from asthrna. N Engl J Med 1992;326:501-6.
11. Sly RM. Mortality from Asthma, 1979-1984. J Allergy Clin Immunol 1988;82:705-17.
12. Weiss KB, Wagener DK. Changing patterns of asthma mortality: identifying target populations at high risk. JAMA 1990;264:1683-7.
13. Weiss KB, Gergen PJ, Hodgson TA. An economic evaluation of asthma in the United States. N Engl J Med 1992; 326:862-6.
14. Robertson C, Smith F, Beck R, et al. Response to frequent low doses of nebulized salbutamol in acute asthma. J Pediatr 1985;106:672-4.
15. Alvine GF, Rodgers PR, Fitzsimmons KM, Ahrens RC. Disposable jet nebulizers. How reliable are they? Chest 1992;101:316-9.
16. Colacone A, Afilalo M, Wolkove N, Kreisman H. A comparison of albuterol administered by metered dose inhaler (and holding chamber) or wet nebulizer in acute asthma. Chest 1993; 104:835-41.